PAX6 Antibody

Immunohistochemistry (FFPE): 1-2ug/ml for 30 minutes at RT

Pax genes contain paired domains with strong homology to genes in Drosophila, which are involved in programming early development. Lesions in the Pax-6 gene account for most cases of aniridia, a congenital malformation of the eye, chiefly characterized by iris hypoplasia, which can cause blindness. Pax-6 is involved in other anterior segment malformations besides aniridia, such as Peters anomaly, a major error in the embryonic development of the eye with corneal clouding with variable iridolenticulocorneal adhesions. The Pax-6 gene encodes a transcriptional regulator that recognizes target genes through its paired-type DNA-binding domain. The paired domain is composed of two distinct DNA-binding subdomains, the amino-terminal subdomain and the carboxy-terminal subdomain, which bind respective consensus DNA sequences. The human Pax-6 gene produces two alternatively spliced isoforms that have the distinct structure of the paired domain.

Purified

1 mg/ml in 1X PBS; BSA free, sodium azide free

A recombinant partial protein (within amino acids 1-300) from the human protein was used as the immunogen for the PAX6 antibody.

This PAX6 antibody is available for research use only.

Nucleus

Protein A/G affinity

P26367